lifestyle.pluralist.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Apotex Inc.
Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals
April 14, 2026
Apotex Announces FDA Approval of First Generic Infuvite® Adult Injection (Single Dose Vial and Pharmacy Bulk package) with 180‑Day CGT Exclusivity for the Pharmacy bulk package in Partnership with Orbicular and Gland Pharma
April 14, 2026
Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular
April 10, 2026
Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar
April 7, 2026
Apotex announces leadership changes
March 30, 2026
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 13, 2026
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 11, 2026
Apotex Receives Health Canada Approval for LOQTORZI® — The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer
October 24, 2025